Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | FABP7 | O15540 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12224099 | 0.85 | HTT (0.42) | HTTLMNAPOLBALDH1A1KMT2A | |
| SCHEMBL24687424 | 0.84 | HTT (0.48) | HTTPOLBALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL28096910 | 0.82 | HTT (0.46) | HTTKDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL967570 | 0.80 | HTT (0.45) | HTTLMNAALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL25447803 | 0.78 | MEN1 (0.48) | HTTPOLBALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL30631642 | 0.78 | SMN1; SMN2 (0.36) | HTTLMNAPOLBKDM4EL3MBTL1 | |
| SCHEMBL7769996 | 0.77 | HTT (0.42) | HTTALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL7769991 | 0.77 | HTT (0.42) | HTTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL12223162 | 0.77 | ACHE (0.47) | HTTL3MBTL1ALDH1A1KMT2AMEN1 | |
| SCHEMBL29362788 | 0.77 | HTT (0.42) | HTTPOLBALDH1A1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2316822-B1 | PREPARATION OF CARBAMATES WITH SOLID CATALYSTS | CONSEJO SUPERIOR INVESTIGACION (ES) | 2016-10-26 | — | — | EP | disclosed |
| US-20150221987-A1 | ELECTROLYTIC SOLUTION FOR NON-AQUEOUS SECONDARY BATTERY, AND NON-AQUEOUS ELECTROLYTIC SOLUTION SECONDARY BATTERY | FUJIFILM CORPORATION (JP) | 2015-08-06 | — | — | US | disclosed |
| US-8735621-B2 | Preparation of carbamates with solid catalysts | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2014-05-27 | — | — | US | disclosed |
| US-20110124902-A1 | PREPARATION OF CARBAMATES WITH SOLID CATALYSTS | Consejo Superior De Investigaciones Cientificas C/Serrano, 117 (ES) | 2011-05-26 | — | — | US | disclosed |
| EP-2316822-A1 | PREPARATION OF CARBAMATES WITH SOLID CATALYSTS | Consejo Superior De Investigaciones Científicas (ES) | 2011-05-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110124902-A1 | PREPARATION OF CARBAMATES WITH SOLID CATALYSTS | ODC1, RCC1, OTC | HTT 566/4885LMNA 1377/4885POLB 1407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.